HC Wainwright & Co. Maintains Buy on Precigen, Raises Price Target to $11

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $10 to $11.